Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study indicates that cross-reactive immunity against SARS-CoV-2 N protein was present in Africa prior to the pandemic

Study indicates that cross-reactive immunity against SARS-CoV-2 N protein was present in Africa prior to the pandemic

1 Aug 2022
What is the role of vitamin D in pandemic H1N1 influenza and SARS-CoV-2 infection?

What is the role of vitamin D in pandemic H1N1 influenza and SARS-CoV-2 infection?

1 Aug 2022
How long can cognitive impairment persist after hospitalization due to COVID-19?

How long can cognitive impairment persist after hospitalization due to COVID-19?

1 Aug 2022
What is the immunopathogenesis of pediatric COVID-19?

What is the immunopathogenesis of pediatric COVID-19?

1 Aug 2022
Meta-analysis on the persistence and prognosis of taste and smell dysfunction in COVID-19 patients

Meta-analysis on the persistence and prognosis of taste and smell dysfunction in COVID-19 patients

1 Aug 2022
Community spread of COVID-19 in New York City revealed by contact tracing

Community spread of COVID-19 in New York City revealed by contact tracing

1 Aug 2022
The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

The susceptibility of transplantable ocular tissues to SARS-CoV-2 lineage A variant infection

1 Aug 2022
Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

31 Jul 2022
Is cannabidiol effective against COVID-19?

Is cannabidiol effective against COVID-19?

31 Jul 2022
Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

Study finds asymptomatic SARS-CoV-2 infection induced comparable memory B cell responses to mild symptomatic infection in young adults

29 Jul 2022
SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

29 Jul 2022
One Health approach for emergent and resurgent infectious diseases

One Health approach for emergent and resurgent infectious diseases

29 Jul 2022
Tannins as therapeutic agents against SARS-CoV-2

Tannins as therapeutic agents against SARS-CoV-2

29 Jul 2022
Study explores the role of endemic coronaviruses-induced cross-immunity in protection against severe COVID-19

Study explores the role of endemic coronaviruses-induced cross-immunity in protection against severe COVID-19

29 Jul 2022
Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

29 Jul 2022
Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

29 Jul 2022
To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

29 Jul 2022
Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

Knowledge, attitudes, and practices of medical professionals towards monkeypox in Italy

29 Jul 2022
Moderna COVID vaccine is more effective in older and sicker veterans over time

Moderna COVID vaccine is more effective in older and sicker veterans over time

28 Jul 2022
The global mutation landscape of the SARS-CoV-2 non-structural protein 1

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

28 Jul 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback